It is reported that NPs encapsulating IL‐2 and TGF‐β coated with anti‐CD2/CD4 antibodies resulted in an expansion of Tregs in vivo and alleviated SLE phenotypes in mouse models.51 Here, TGFB1 is linked to systemic lupus erythematosus.